| Q49632805 | A 13-year real-life study on efficacy, safety and biological effects of Vespula venom immunotherapy |
| Q50788965 | Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom. |
| Q39366204 | Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis. |
| Q41262793 | Decline of Ves v 5-specific blocking capacity in wasp venom-allergic patients after stopping allergen immunotherapy |
| Q42028781 | Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy |
| Q36829985 | Duration of allergen immunotherapy in respiratory allergy: when is enough, enough? |
| Q38658310 | EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy. |
| Q58617547 | Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy |
| Q37585269 | Food-induced anaphylaxis: mast cells as modulators of anaphylactic severity |
| Q34564746 | Hymenoptera (apid and vespid) allergy: update in diagnosis and management |
| Q93186376 | Hymenoptera Venom Allergy: How Does Venom Immunotherapy Prevent Anaphylaxis From Bee and Wasp Stings? |
| Q58617695 | Hymenoptera venom allergy |
| Q37842330 | Hymenoptera venom immunotherapy |
| Q37931150 | Insect allergy |
| Q36404340 | Insect sting allergy and venom immunotherapy |
| Q24672123 | Insect sting anaphylaxis |
| Q47656689 | Insect sting anoxic encephalopathy after stopping venom immunotherapy |
| Q52689135 | Long-term efficacy of venom immunotherapy. |
| Q24631273 | Management of insect sting hypersensitivity: an update |
| Q36350581 | Peptide-based immunotherapy: a novel strategy for allergic disease |
| Q44459579 | Predictors of clinical effectiveness of Hymenoptera venom immunotherapy. |
| Q91837709 | Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy |
| Q37039548 | Short-, Intermediate-, and Long-Term Changes in Basophil Reactivity Induced by Venom Immunotherapy. |
| Q37355616 | Single venom-based immunotherapy effectively protects patients with double positive tests to honey bee and Vespula venom |
| Q51982702 | Skin testing technique and precision in stinging insect allergy. |
| Q77873668 | Stinging insect hypersensitivity: a practice parameter. The Joint Force on Practice Parameters, the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma |
| Q52576369 | Survey of patients after discontinuing venom immunotherapy. |
| Q79429545 | Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy |
| Q44925500 | Usefulness and limitations of sequential serum tryptase for the diagnosis of anaphylaxis in 102 patients. |
| Q46248572 | Venom immunotherapy in patients with allergic reactions to insect stings |